Glaucoma Market Scope And Analysis

  • Report Code : TIPRE00006204
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Glaucoma Market Analysis and Share - 2031

Buy Now

Glaucoma Market Report Glaucoma Market Size and Share Glaucoma Market Scope and Analysis

Glaucoma Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 4.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Disease Indication
  • Closed Angle Glaucoma
  • Open Angle Glaucoma
  • Secondary Glaucoma
  • Congenital Glaucoma
By Drug Class
  • Prostaglandin Analogs
  • Alpha Agonist
  • Beta Blockers
  • Cholinergic Drugs
  • Carbonic Anhydrase Inhibitors
By Surgery
  • Laser Iridotomy
  • Laser Trabeculoplasty
  • Aqueous Shunt Surgery and Peripheral Iridectomy
By End Users
  • Hospitals
  • Clinics
  • Home Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Pfizer Inc
  • Allergan
  • Merck Co
  • Ocular Therapeutix Inc
  • pSivida Corp
  • Icon Bioscience Inc
  • Amorphex Therapeutics LLC
  • Ellex